I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
ASCOT ADAPT study of COVID-19 therapeutics in hospitalised ..:
Justin T. Denholm
;
Balasubramanian Venkatesh
;
Joshua Davis
...
https://doi.org/10.1186/s13063-022-06929-y. , 2022
Link:
https://doi.org/10.1186/s13063-022-06929-y
RT Journal T1
ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:1525711e1b7c4e0ca57b319ae46b89a6&Exemplar=1&LAN=DE A1 Justin T. Denholm A1 Balasubramanian Venkatesh A1 Joshua Davis A1 Asha C. Bowen A1 Naomi E. Hammond A1 Vivekanand Jha A1 Grace McPhee A1 Zoe McQuilten A1 Matthew V. N. O'Sullivan A1 David Paterson A1 David Price A1 Megan Rees A1 Jason Roberts A1 Mark Jones A1 James Totterdell A1 Thomas Snelling A1 Nanette Trask A1 Susan Morpeth A1 Steven YC Tong A1 on behalf of the ASCOT ADAPT investigators PB BMC YR 2022 K1 COVID-19 K1 SARS-CoV-2 K1 Randomised controlled trial K1 Antiviral medication K1 Anticoagulation K1 Antibody K1 Medicine (General) K1 R5-920 JF https://doi.org/10.1186/s13063-022-06929-y LK http://dx.doi.org/https://doi.org/10.1186/s13063-022-06929-y DO https://doi.org/10.1186/s13063-022-06929-y SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)